VP, Data Science, Neuroscience Therapeutic Area
Vaibhav is currently Vice President, Digital Health Innovation in the ‘Science for Minds’ initiative at Johnson & Johnson, responsible for utilizing internal and external partnerships to develop data driven, evidence based digital health technology solutions in mental health, neurodegeneration and brain health. Prior to this, Vaibhav was Vice President and Head of Data Science for the Neuroscience Therapeutic Area within Janssen R&D. In that role, Vaibhav built and lead a team responsible applying advanced analytics to genetic, molecular, clinical and digital phenotyping data to gain disease insights, discover novel drug targets and enable precision and predictive medicine strategies in Neuroscience. Vaibhav has pioneered use of data derived from wearable sensors and smartphones to develop digital biomarkers for early detection, disease progression, drug response, treatment monitoring and relapse prediction in Alzheimer’s, Mood and Schizophrenia.
Vaibhav joined Johnson and Johnson in 2009, from Eli Lilly and Co., where he was the Head of Discovery and Medical Informatics group. Prior to Lilly, Vaibhav held multiple leadership roles in bioinformatics and genomics start-up companies, including Celera Genomics where he participated in the sequencing, assembly and analysis of the human genome.
Vaibhav obtained his PhD from Yale University in Computational Biology in 1998 and an Executive MBA from Kellogg School of Management, Northwestern University in 2009.